Leadership
Meet the Magnolia Medical Technologies team of industry leaders– all working toward one common vision.
Board of Directors
Jason Richey
President & Chief Executive Officer
Ron A. Lowy
CEO & Executive Chairman, The RAL Group, LLC
Paul Enever, PhD
Managing Director – Evidity Health Capital
Kathryn Beal, M.D.
Radiation Oncologist, Memorial Sloan Kettering Cancer Center
Marc-André Marcotte
Partner & Chief Operating Officer, Sectoral Asset Management
Gaurav Aggarwal, M.D.
Managing Partner, Vivo Capital
Robert Rapaport
Analyst, RTW Investments, LP
Medical and Scientific Advisory Board
David T. Durack, M.D.
Chairman, Consulting Professor of Medicine, Duke University
Daniel J. Sexton, M.D.
Professor of Medicine, Duke University
Franklin R. Cockerill, III, M.D.
CEO of FRC3Lab
William J. McDaniel, M.D.
Rear Admiral, U.S. Navy (ret)
Gary V. Doern, PhD
Professor Emeritus, Dept. of Pathology University of Iowa Carver School of Medicine
Richard M. Ivey
WW Vice President R&D - BD Life Sciences (Retired)
Paul Goldenbaum, PhD
President, Texas Microbiology Consultants, LLC
We’re on a mission to improve the diagnostic accuracy and timeliness of sepsis test results.